Research analysts at StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a “buy” rating and issued a $11.00 price objective on shares of Onconova Therapeutics in a report on […]
StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a report released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 target price on shares of Onconova Therapeutics in a research report on Thursday, October 12th. […]
Onconova Therapeutics, Inc. (NASDAQ:ONTX – Get Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 142,100 shares, a decline of 51.5% from the December 15th total of 293,000 shares. Based on an average daily trading volume, of 263,500 […]
StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research report sent to investors on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a buy rating and set a $11.00 price target on shares of Onconova Therapeutics in a research note on […]
Onconova Therapeutics, Inc. (NASDAQ:ONTX – Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 293,000 shares, a growth of 694.0% from the November 30th total of 36,900 shares. Based on an average trading volume of 256,700 shares, […]